Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Palo Alto Networks Inc (PANW) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Palo Alto Networks IncTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Palo Alto Networks Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Palo Alto Networks Inc trades at $371.5 (market cap $324.77B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Palo Alto Networks Inc is far larger — about 30.1× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Palo Alto Networks Inc for 82 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

PANWRDY
Market Cap
$324.77B$10.78B
Volume
3,473,7832,724,343
Sector
TechnologyHealth
52-Week High
$419.91$15.38
52-Week Low
$141.67$11.38
Typical Hold Time
82 Days0 Days
Enterprise Value
$324.20B$10.68B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Palo Alto Networks Inc

Palo Alto Networks (PANW) trades at $375.04, down 7.13% over the past day but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive sentiment from 64 buy ratings. Recent earnings beats and robust revenue growth to $9.22B in 2025 highlight fundamental strength, though valuation ratios remain elevated with a P/E of 992.58. The company's AI-driven security platform and continuous defense services are key growth drivers, positioning it well in the cybersecurity sector.

Outlook: PANW's AI integration and platformization strategy support long-term growth, with a consensus price target of $400.05 offering ~6.7% upside. Risks include premium valuation, rising costs, and competitive pressures. Investors should weigh strong fundamentals against high multiples.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PANW
52% Buy48% Sell
Avg holding period · 82 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Palo Alto Networks Inc

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.

Read more on PANW →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →